Consun Pharmaceutical Group Ltd
HKEX:1681
Consun Pharmaceutical Group Ltd
Income from Continuing Operations
Consun Pharmaceutical Group Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Consun Pharmaceutical Group Ltd
HKEX:1681
|
Income from Continuing Operations
¥786.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income from Continuing Operations
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income from Continuing Operations
¥3.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income from Continuing Operations
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income from Continuing Operations
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Income from Continuing Operations
-¥780.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Consun Pharmaceutical Group Ltd's Income from Continuing Operations?
Income from Continuing Operations
786.6m
CNY
Based on the financial report for Dec 31, 2023, Consun Pharmaceutical Group Ltd's Income from Continuing Operations amounts to 786.6m CNY.
What is Consun Pharmaceutical Group Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
18%
Over the last year, the Income from Continuing Operations growth was 15%. The average annual Income from Continuing Operations growth rates for Consun Pharmaceutical Group Ltd have been 18% over the past three years , 10% over the past five years , and 18% over the past ten years .